BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND PRDM16, KIAA1675, 63976, ENSG00000142611, MEL1, PFM13, Q9HAZ2 AND Diagnosis
6 results:

  • 1. Transcription analysis of a histones modifiers panel coupled with critical tumor suppressor genes displayed frequent changes in patients with AML.: mRNA levels of histones modifiers and TSGs in AML.
    Amiri V; Mohammadi MH; Rafiee M; Ghezelbash B; Salari S; Allahbakhshian Farsani M
    Curr Res Transl Med; 2021 Oct; 69(4):103311. PubMed ID: 34455155
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia.
    Wang J; Pan J; Huang S; Li F; Huang J; Li X; Ling Q; Ye W; Wang Y; Yu W; Jin J
    BMC Med; 2021 Feb; 19(1):28. PubMed ID: 33517886
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. High
    Dao FT; Chen WM; Long LY; Li LD; Yang L; Wang J; Liu YR; Jiang H; Zhang XH; Jiang Q; Qin YZ
    Leuk Lymphoma; 2021 Jan; 62(1):185-193. PubMed ID: 32902355
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Current diagnosis and treatment for pediatric acute myeloid leukemia].
    Shiba N
    Rinsho Ketsueki; 2017; 58(4):389-399. PubMed ID: 28484171
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. prdm16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.
    Duhoux FP; Ameye G; Montano-Almendras CP; Bahloula K; Mozziconacci MJ; Laibe S; Wlodarska I; Michaux L; Talmant P; Richebourg S; Lippert E; Speleman F; Herens C; Struski S; Raynaud S; Auger N; Nadal N; Rack K; Mugneret F; Tigaud I; Lafage M; Taviaux S; Roche-Lestienne C; Latinne D; Libouton JM; Demoulin JB; Poirel HA; ;
    Br J Haematol; 2012 Jan; 156(1):76-88. PubMed ID: 22050763
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. RUNX1 DNA-binding mutations and RUNX1-prdm16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.
    Roche-Lestienne C; Deluche L; Corm S; Tigaud I; Joha S; Philippe N; Geffroy S; Laï JL; Nicolini FE; Preudhomme C;
    Blood; 2008 Apr; 111(7):3735-41. PubMed ID: 18202228
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.